Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pd-1 and Pd-L1 Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pd-1 and Pd-L1 Inhibitorsmarket, defines the market attractiveness level of Pd-1 and Pd-L1 Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pd-1 and Pd-L1 Inhibitors industry, describes the types of Pd-1 and Pd-L1 Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pd-1 and Pd-L1 Inhibitors market and the development prospects and opportunities of Pd-1 and Pd-L1 Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pd-1 and Pd-L1 Inhibitors market in Chapter 13.
By Player:
Pfizer
Novartis
Merck
Gilead Sciences
AstraZeneca
Sanofi
Celgene
Amgen
F Hoffmann-La Roche
Bristol-Myers Squibb
By Type:
PD-1
PD-L1
By End-User:
Hospital Pharmacies
Retail Pharmacies
Specialty Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pd-1 and Pd-L1 Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pd-1 and Pd-L1 Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pd-1 and Pd-L1 Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pd-1 and Pd-L1 Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pd-1 and Pd-L1 Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Pd-1 and Pd-L1 Inhibitors Consumption (2017-2022)
-
7.2 United States Pd-1 and Pd-L1 Inhibitors Consumption (2017-2022)
-
7.3 Europe Pd-1 and Pd-L1 Inhibitors Consumption (2017-2022)
-
7.4 China Pd-1 and Pd-L1 Inhibitors Consumption (2017-2022)
-
7.5 Japan Pd-1 and Pd-L1 Inhibitors Consumption (2017-2022)
-
7.6 India Pd-1 and Pd-L1 Inhibitors Consumption (2017-2022)
-
7.7 South Korea Pd-1 and Pd-L1 Inhibitors Consumption (2017-2022)
8 Region and Country-wise Pd-1 and Pd-L1 Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Pd-1 and Pd-L1 Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Pd-1 and Pd-L1 Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Pd-1 and Pd-L1 Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Pd-1 and Pd-L1 Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Pd-1 and Pd-L1 Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Pd-1 and Pd-L1 Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Pd-1 and Pd-L1 Inhibitors Consumption Forecast (2022-2028)
9 Global Pd-1 and Pd-L1 Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Pd-1 and Pd-L1 Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global PD-1 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global PD-L1 Consumption and Growth Rate (2017-2022)
-
9.2 Global Pd-1 and Pd-L1 Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Specialty Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Pd-1 and Pd-L1 Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Pd-1 and Pd-L1 Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global PD-1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global PD-L1 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pd-1 and Pd-L1 Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Specialty Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Pd-1 and Pd-L1 Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pd-1 and Pd-L1 Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pd-1 and Pd-L1 Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pd-1 and Pd-L1 Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pd-1 and Pd-L1 Inhibitors Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Pd-1 and Pd-L1 Inhibitors Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Pd-1 and Pd-L1 Inhibitors Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Pd-1 and Pd-L1 Inhibitors Product and Service
-
14.4 Gilead Sciences
-
14.4.1 Gilead Sciences Company Details
-
14.4.2 Gilead Sciences Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Gilead Sciences Pd-1 and Pd-L1 Inhibitors Product and Service
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Details
-
14.5.2 AstraZeneca Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Pd-1 and Pd-L1 Inhibitors Product and Service
-
14.6 Sanofi
-
14.6.1 Sanofi Company Details
-
14.6.2 Sanofi Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sanofi Pd-1 and Pd-L1 Inhibitors Product and Service
-
14.7 Celgene
-
14.7.1 Celgene Company Details
-
14.7.2 Celgene Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Celgene Pd-1 and Pd-L1 Inhibitors Product and Service
-
14.8 Amgen
-
14.8.1 Amgen Company Details
-
14.8.2 Amgen Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Amgen Pd-1 and Pd-L1 Inhibitors Product and Service
-
14.9 F Hoffmann-La Roche
-
14.9.1 F Hoffmann-La Roche Company Details
-
14.9.2 F Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 F Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Product and Service
-
14.10 Bristol-Myers Squibb
-
14.10.1 Bristol-Myers Squibb Company Details
-
14.10.2 Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pd-1 and Pd-L1 Inhibitors
-
Figure Pd-1 and Pd-L1 Inhibitors Picture
-
Table Global Pd-1 and Pd-L1 Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pd-1 and Pd-L1 Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pd-1 and Pd-L1 Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pd-1 and Pd-L1 Inhibitors Consumption by Country (2017-2022)
-
Figure United States Pd-1 and Pd-L1 Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Pd-1 and Pd-L1 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Pd-1 and Pd-L1 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Pd-1 and Pd-L1 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Pd-1 and Pd-L1 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pd-1 and Pd-L1 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Pd-1 and Pd-L1 Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Pd-1 and Pd-L1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pd-1 and Pd-L1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pd-1 and Pd-L1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pd-1 and Pd-L1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pd-1 and Pd-L1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pd-1 and Pd-L1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PD-1 Consumption and Growth Rate (2017-2022)
-
Figure Global PD-L1 Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Specialty Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global PD-1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PD-L1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialty Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pd-1 and Pd-L1 Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pd-1 and Pd-L1 Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Pd-1 and Pd-L1 Inhibitors Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Pd-1 and Pd-L1 Inhibitors Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Pd-1 and Pd-L1 Inhibitors Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Pd-1 and Pd-L1 Inhibitors Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Pd-1 and Pd-L1 Inhibitors Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Pd-1 and Pd-L1 Inhibitors Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Pd-1 and Pd-L1 Inhibitors Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Pd-1 and Pd-L1 Inhibitors Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Product and Service
-
